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Abstract
The metabolic adaptations to fasting in the liver are largely controlled by the nuclear hormone receptor peroxisome
proliferator-activated receptor alpha (PPARa), where PPARa upregulates genes encoding the biochemical pathway for b-
oxidation of fatty acids and ketogenesis. As part of an effort to identify and characterize nutritionally regulated genes that
play physiological roles in the adaptation to fasting, we identified Major facilitator superfamily domain-containing protein 2a
(Mfsd2a) as a fasting-induced gene regulated by both PPARa and glucagon signaling in the liver. MFSD2A is a cell-surface
protein homologous to bacterial sodium-melibiose transporters. Hepatic expression and turnover of MFSD2A is acutely
regulated by fasting/refeeding, but expression in the brain is constitutive. Relative to wildtype mice, gene-targeted Mfsd2a
knockout mice are smaller, leaner, and have decreased serum, liver and brown adipose triglycerides. Mfsd2a knockout mice
have normal liver lipid metabolism but increased whole body energy expenditure, likely due to increased b-oxidation in
brown adipose tissue and significantly increased voluntary movement, but surprisingly exhibited a form of ataxia. Together,
these results indicate that MFSD2A is a nutritionally regulated gene that plays myriad roles in body growth and
development, motor function, and lipid metabolism. Moreover, these data suggest that the ligand(s) that are transported by
MFSD2A play important roles in these physiological processes and await future identification.
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Introduction
The rampant obesity epidemic has led to interrelated increases
in cardiovascular disease, hepatic steatosis, and diabetes [1–5]. A
better understanding of how the body uses excess nutrients and
switches between anabolic and catabolic states is crucial to
advance clinical treatments. The nuclear hormone receptor
PPARa acts as a master regulator, along with adrenergic and
hormonal signals, to increase fatty acid oxidation (FAO) [6] and
gluconeogenesis [7], as well as ketogenesis during the latter stages
of a fast (.12 h) [8,9]. The PPARa knockout (KO) mouse
constructed by Gonzalez and colleagues proved the importance of
PPARa in coordinating the transcriptional response to fasting in
liver [10]. FAO in brown adipose tissue (BAT) is also regulated in
a PPARa-dependent manner and promotes non-shivering ther-
mogenesis via uncoupled oxidative phosphorylation in response to
adrenergic and hormonal (particularly thyroid) signals [11,12].
With the recent demonstration of BAT in adult humans, this
pathway has gained significance in its potential for therapeutic
intervention [13,14].
In an effort to understand the physiological processes that
govern the metabolic transition from fed to fasted state, we used
a microarray approach to identify novel PPARa targets in liver
[15]. From this screen we identified the plasma membrane
protein, Major facilitator superfamily domain-containing protein 2a
(Mfsd2a). The Major Facilitator Superfamily (MFS) is one of the
largest families of transporters, consisting of 74 functionally diverse
subfamilies, with ligands ranging from simple and complex sugars
and amino acids to drugs and organic anions [16]. The majority of
MFS porters share a 12-transmembrane domain homology made
of two evolutionary duplicated 6-transmembrane units. Mfsd2a is
phylogenetically conserved from fish to human, and a recent study
reported a predicted structure of 12 transmembrane domains with
a 29% identity to the bacterial sodium-melibiose transporter,
MelB [17].
Human, but not mouse, MFSD2A was also identified as the
target for syncytin-2, where syncytin-2 binding to MFSD2A
induces cell fusion and thus likely plays an important role in
syncytiotrophoblast development in human placenta [18]. Addi-
tionally Angers et al. reported Mfsd2a mRNA is induced in mouse
liver by fasting and in BAT by fasting, cold exposure, and b-
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adrenergic signaling, indicating a potential physiological role in
lipid metabolism and energy expenditure [17].
In the current study, our goal was to determine the regulatory
pathways that control Mfsd2a expression in response to fasting,
and to determine a physiological role for MFSD2A using a gene-
targeted Mfsd2a-deficient mouse model. We provide evidence
that MFSD2A plays an important role in regulating lipid
metabolism, growth and development, and motor function, and




A polyclonal MFSD2A antibody was raised in rabbits against
the c-terminal peptide H-CSDTDSTELASIL-OH (NeoMPS, San
Diego, CA). Serum was purified on polyA/G resin followed by
affinity purification against the peptide immobilized on Sulfolink
resin (ThermoScientific). Other antibodies used in these studies
include: b-actin (Sigma), Tom20 (Santa Cruz), Cox4 (Cell Signal),
and UCP1 (Abcam). Mouse and human Mfsd2a cDNA was
subcloned into pcDNA3.1 (Invitrogen).
Cell Culture
HEK293 cells (ATCC) were cultured in DMEM (Invitrogen)
with 10% fetal bovine serum and penicillin/streptomycin at 37uC
with 5% CO2. Sub-confluent cells were transiently transfected for
12 h using Lipofectamine 2000 (Invitrogen) 24–48 h prior to
experimentation.
Primary Hepatocyte Isolation
Primary hepatocytes were isolated according to our previously
published protocol [19].
Protein Turnover Assays
Cycloheximide (CHX, 0.1 mg/ml) in fresh media was added to
wells at the beginning of an experiment. Where indicated, 100 mM
chloroquine (in H2O) or 10 mM MG-132 (in DMSO) was added
2 h prior to addition of CHX and maintained in the media
throughout the end of the experiment. To biotinylate surface
proteins, cells were washed on ice three times with cold PBS and
incubated with freshly made maleimide-PEG2-Biotin (Thermo-
Scientific) in PBS for one hour. Excess biotin was washed away
three times in cold PBS with 1 mM DTT. Protein was extracted as
below. Equal volumes of protein extract and streptavidin agarose
slurry (Pierce ThermoScientific) were mixed and washed three
times. Samples were rotated overnight at 4uC, washed three times,
and mixed with a volume of SDS-Laemmli buffer. The
supernatant was analyzed by SDS-PAGE.
Western Blotting
Mouse tissues were ground with a dounce homogenizer on ice
in RIPA buffer with EDTA-free cOmplete protease inhibitor
cocktail (Roche). Cell cultures were washed with cold PBS and
scraped with cold RIPA buffer. Protein concentration was
measured with a Bradford assay (BioRad). Protein samples
(40 mg protein/lane) were separated by SDS-PAGE, transferred
to nitrocellulose membranes (Bio-Rad), and incubated overnight
with primary antibodies. Protein bands were quantified from
infrared-linked secondary antibodies using an Odyssey infrared
scanner (Li-Cor).
Animal Models
A conventional KO mouse model was engineered following
standard BAC recombineering protocols [20]. BAC RP23-306M6
was obtained from Children’s Hospital Oakland Research In-
stitute. The engineered targeting vector replaced exons 4 through
13 with a PGK-Neomycin cassette, available from the NIH
Division of Technology Development and Transfer Office. The
Figure 1. MFSD2A expression is nutritionally regulated and requires PPARa and glucagon signaling. A, Representative Western blot of
MFSD2A expression in the indicated tissues isolated from WT mice that were ad libitum fed, fasted for 24 h, or fasted for 24 h and ad libitum refed
(n = 3 mice per condition). B, Western blot of liver samples from fed and fasted wildtype (WT) and PPARa knockout (KO) mice (n = 4 per genotype per
condition). C, Western blot of livers from two glucagon receptor (Gcgr KO)-deficient mice and two WT fasted littermates probed for MFSD2A
expression (n = 6–7). D, Western blot for MFSD2A from liver samples of 24 h fasted WT mice (0 h), and mice fasted, refed and sacrificed 1 to 9 h after
refeeding. b-actin served as a loading control in all panels. Each lane represents a liver sample from an individual animal.
doi:10.1371/journal.pone.0050629.g001
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vector was introduced into embryonic stem cells, and gene-
targeted cells were implanted in C57BL/6J surrogate mothers.
Mfsd2a KO mice used in these studies were backcrossed onto
C57BL/6J for 5–10 generations. Gcgr KO mice, also on
a C57BL/6J background, were previously described [21]. PPARa
KO mice (Jackson Laboratory) were previously described [22].
Genotyping was performed on genomic DNA extracted from tail
tips, using forward primer Mfsd2a TVP 1F 59-GGCTTCAGG-
CACCCTGGCAAGTCCTAG-39 and reverse primers PGK-R-
TVP 59-GCTTGGCTGGACGTAAACTCCTCTTCAGACC-
39 and Mfsd2a Intron 13 59-GCCCTGTGTTCTAGCCA-
CAACCTGTATTCTG-39. Sex determination of neonates was
performed as previously published [23].
Animal Studies
Experimental protocols were approved by the Albert Einstein
College of Medicine Institutional Animal Care and Use Commit-
tee. Mice were maintained on a 12 h light cycle on breeder chow
(LabDiet #5058) or 60 kcal% high-fat diet (Research Diets, Inc.
#D12492) as indicated. In all instances, ‘‘fasted’’ indicates an
overnight (18–24 h) fast with ad libitum access to water. For the
indicated studies, mice were weighed weekly. For glucose
measurements, blood was collected from the tail vein and
measured using a glucometer (Accu-Check Compact, Roche).
For tolerance tests, overnight fasted mice were injected with bolus
glucose (1 g/kg i.p.) or pyruvate (2 g/kg i.p.). Serum obtained by
retro-orbital bleed was analyzed using colorimetric assays for total
cholesterol and triglyceride (Infinity), ketone bodies (Stanbio), and
non-esterified fatty acids (Wako). Total T3 and T4 levels were
determined by RIA (MP Biologicals). Metabolic studies were
conducted in a CLAMS (Columbus Instruments) indirect
calorimetry system to obtain measures of oxygen consumption,
carbon dioxide production, and physical activity. Mice acclimated
to individual chambers for 2 days, followed by 4 days of data
collection (48 h ad libitum feeding, 24 h fasting, and 24 h ad libitum
refeeding). Data were normalized to lean body mass. Body mass
was assessed with EchoMRI (Houston, TX). Tissue lipids were
extracted from the volume of 1 mg protein (homogenized in PBS)
with two volumes of 2:1 chloroform:methanol. The organic phase
was dried under nitrogen, resuspended in 1% Triton X-100, and
quantified as above.
VLDL Synthesis Assay
Mice were fasted for 4 h to clear chylomicrons from circulation,
and injected with filter-sterilized Plurionic F-127 (1 mg/g BW i.p.)
in PBS [24,25]. Blood was collected immediately prior to injection
(t = 0) and thereafter hourly up to 4 h, and analyzed for serum TG
and cholesterol concentrations as described above.
In vivo Fatty Acid Uptake Assay
Fasted animals received i.p. injections of PBS with 1 mM
oleate/BSA and 2 mCi [14C]-oleate/BSA. Mice were sacrificed
after 1 h, perfused with PBS, and tissues were removed, weighed,
and snap-frozen. Whole tissue was ground in PBS, scintillation
counted, and normalized as both as cpm per g wet weight and per
mg protein.
Figure 2. MFSD2A is rapidly turned over from the cell surface via the lysosome. A, MFSD2A turnover as a function of time in
cycloheximide-treated (CHX) HEK293 cells transfected with mouse Mfsd2a and primary hepatocytes from fasted mice. Time indicates duration of CHX
treatment. Graph quantifies MFSD2A expression. B, Turnover of plasma membrane MFSD2A in Mfsd2a-transfected HEK293 cells. Cells were incubated
with CHX for the indicated time period and then treated with membrane-impermeable maleimide-PEG2-Biotin. Protein homogenates were
immunoprecipitated with streptavidin beads, prior to Western blot analysis for plasma membrane localized MFSD2A. C and D, Mfsd2a-transfected
HEK293 cells were treated with CHX as in panel A, with or without (C) chloroquine (CLQ) or (D) MG-132 (Western blot not shown). Protein extracts
were analyzed by Western blot for MFSD2A. Graphs quantify MFSD2A expression. b-actin in A and C and Na-K-ATPase in B served as a loading control.
Quantification represents experiments in triplicate, displayed as mean 6 SD.
doi:10.1371/journal.pone.0050629.g002
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Fatty Acid Re-Esterification Assay
Transfected HEK293 cells were incubated with either 0.5 mCi
[14C]-glycerol or 100 mM oleate/BSA with 0.4 mCi/ml [14C]-
oleate/BSA in KRPH buffer (5 mM NaH2PO4, 20 mM HEPES,
1 mM MgSO4, 1 mM CaCl2, 136 mM NaCl, 4.7 mM KCl) for
3 h at 37uC. Cells were washed with 100 mM oleate/BSA in PBS,
air dried, and lipids were extracted with 3:2 hexane/isopropanol.
Thin layer chromatography (TLC) separation of extracted lipids
was performed as previously described [26]. Signals were
normalized to total protein extracted from cells with 0.1 N
NaOH/0.1% SDS solution.
Measurement of b-oxidation in Liver Homogenate
As modified from [27], perfused liver was excised, weighed, and
immediately homogenized in ice-cold buffer (0.25 M sucrose,
1 mM Tris-HCl, 1 mM EDTA pH 7.4 with protease inhibitors).
10 mg worth of liver tissue was added to 4 volumes (,200 ml) of
reaction buffer (150 mM KCl, 10 mM HEPES, 0.1 mM, 1 mM
KH2PO4, 10 mM MgCl2-6H2O, 5 mM malate, 1 mM L-carni-
tine, 5 mM ATP, pH 7.2 with 50 mM Palmitate/BSA and 1 mCi
of [3H]-palmitate/BSA per rxn) and incubated at 37uC for 1 h.
Reaction was stopped with addition of 200 ml 0.6 M perchloric
acid and the media was cleared of debris by centrifugation at
2,0006g for 5 min. One volume of radioactive media was mixed
with nine volumes of 20 mM Tris-HCl, pH 7.5 with 10% w/v
activated charcoal suspension and rotated for 30 min at room
temperature to remove free fatty acids from media. The sample
was centrifuged at 13,0006g for 15 min, and 200 ml of
supernatant was scintillation counted to measure tritiated water.
FAO was calculated as (CPMs sample – CPMs blank) and
converted to nmols palmitate per mg tissue.
In vivo and ex vivo Lipolysis Assays
For measurement of lipolysis in vivo, blood was collected with
non-heparinized capillary tubes for baseline measurement prior
injecting mice with 1 mg/kg BW i.p. CL316243 (Sigma). Blood
was collected 15 min later for serum NEFA measurements [28].
For ex vivo lipolysis assays, adipose tissue explants (,20 mg) from
epididymal fat pads were incubated in Krebs-Ringer buffer
(12 mM HEPES, 121 NaCl, 4.9 mM KCl, 1.2 mM MgSO4 and
0.33 mM CaCl2) with 3.5% fatty acid-free BSA and 3 mM glucose
(KRB), with or without 200 nM isoproterenol (Sigma) at 37uC for
2 h and measured for glycerol (Sigma) and fatty acid (Wako)
production as previously published [29].
Figure 3. Generation of an Mfsd2a KO mouse. A, Schema for conventional Mfsd2a knockout where exons 4–13 were replaced with a neomycin
resistance cassette (NEO). B, PCR genotyping of WT, HET and KO mice with primers indicated in A. C, Western blots of MFSD2A expression in liver and
brain from fasted WT, HET, and KO male mice. D, Western blot of MFSD2A in liver of WT and KO mice exposed to 4uC. E, Western blot analysis of
MFSD2A expression in indicated tissues from fasted WT and KO mice. F, Western blot of MFSD2A expression in the indicated brain regions in WT fed,
WT fasted, and KO fasted mice. b-actin is the loading control in panels C–F. Note: lack of b-actin in heart sample in D is expected based on actin
isoform expression.
doi:10.1371/journal.pone.0050629.g003
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Brown Adipose Function
b-oxidation was measured from bilateral BAT depots isolated
from sacrificed mice, trimmed clean of WAT, weighed, and
incubated in KRB with 50 mM [9,10-3H]-palmitate/BSA
(0.4 mCi/ml) and with or without 200 nM isoproterenol at 37uC
for 2 h. At the endpoint, tissue was snap-frozen in liquid nitrogen,
and the media was clear of debris by centrifugation at 2,0006g for
5 min. The media was washed with charcoal as above to remove
free radioactive palmitate and scintillation counted.
Cold Tolerance Test
Cold-induced thermogenesis was evaluated by exposure to 4uC
for at least 2 h. Animals were fasted, with ad libitum access to water,
and housed individually without bedding. Rectal temperature was
monitored with a Physiotemp IT-23 thermocouple microprobe.
BAT mitochondrial content was assessed by western for Tom20
and CoxIV protein expression, as well as by the ratio of UCP1
DNA copy number to mitochondrial CoxII DNA assessed by real-
time PCR.
Figure 4. Mfsd2a KOmice are smaller and leaner than WT littermates, with reduced serum TG. A, Number of genotype obtained for male
and female day e18.5 embryos (n = 7 litters, 62 embryos) and post-natal day 10 pups (n = 156 litters, 1135 pups). Chi2 analysis gives the probability
that the observed ratios are Mendelian. B, Growth curves of weekly weights of offspring from heterozygous intercrosses for all three genotypes
(average of n = 30 per genotype). Body weights between wildtype and KO mice are significantly different at all time points by week 2. C, Scatterplot of
body lengths indicating average (from nose-to-anus) of WT, HET and KO littermates (n = 6–11). D, Absolute (left panel) and relative (right panel)
adiposity of KO and WT littermates (n = 4–7) was determined by EchoMRI. E, Food intake per mouse, per 24 h (males, 14–16 weeks of age, n.5 per
genotype). F, GTT of 14-week old chow-fed WT and KO males after overnight fast (n = 4). G, Metabolites and thyroid hormone from WT and KO male
littermates, fed or post-18–24 h fast as indicated (n.4). Data are average 6 SEM, * p,0.05, ** p,0.01, *** p,0.001, N.S. = not significant, N.D. = not
determined.
doi:10.1371/journal.pone.0050629.g004
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Histology
Adipose samples were fixed in 10% formalin for 24 h followed
by 70% ethanol, prior to paraffin embedding, sectioning, and
staining by hematoxylin and eosin (H&E). Liver was frozen in
OCT medium for Oil Red-O staining.
Neurologic Assessment
Analysis of motor coordination and balance was objectively
measured by performance on an accelerating rotarod. Mice were
trained and tested with three trials per day for 3 days starting at
a speed of five rotations per minute, with a 0.1 rpm/sec increase
for no longer than 5 min, measuring latency to fall-off.
mRNA Transcript Analysis
Mouse liver and BAT RNA was isolated with Trizol, and cDNA
was synthesized using a SuperScript III first-strand cDNA
synthesis kit (Invitrogen). Quantitative real-time PCR was
preformed using SYBR Green on a 7500 Fast system (Applied
Biosystems). Relative quantification of each target was normalized
Figure 5. Mfsd2a KO mice have decreased liver TG with normal liver metabolism. Oil red-O histology of fasted A, WT and B, KO liver
illustrates neutral lipid stores. C, Quantification of TG extracted from fed and fasted WT and KO livers. D, Assay of b-oxidation in liver homogenates
from fasted WT and KO littermates (n = 3–4 per genotype, data representative of three independent experiments). E, In vivo uptake of 14C-oleate in
indicated tissues from WT and KO mice, normalized to heart uptake (n = 3 per genotype). F, TLC of lipid extract illustrating in vitro incorporation of
14C-glycerol and 14C-oleate by control and Mfsd2a-transfected HEK293 cells (n = 3). CE, cholesterol ester; M/D/TAG, mono-, di-, tri-acylglycerol; PL,
phospholipids. G-H, In vivo VLDL production was assayed by measuring G, serum TG and H, cholesterol in fasted WT and KO mice (n.5 per genotype)
following treatment with LPL-inhibitor F-127. I, Real-time PCR analysis of PPARa targets and fatty acid synthesis genes from fasted WT and KO liver
(n = 3–4). J, Pyruvate tolerance test of 12–14-week old chow-fed WT and KO littermates after an overnight fast (n = 6). Data are displayed as mean 6
SEM. * p,0.05, ** p,0.01.
doi:10.1371/journal.pone.0050629.g005
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to HPRT for liver and ribosomal 18S for BAT. Primer (Invitrogen)
sequences are available on upon request.
Results
Fasting-induced Expression of MFSD2A Requires PPARa
and Glucagon Signaling
In order to study the regulation and expression of MFSD2A,
a polyclonal antibody was raised against the c-terminus of mouse
MFSD2A. We verified that mouse MFSD2A has two glycosylation
sites at Asn-221 and Asn-231 (homologous to the sites Asn-217
and Asn-227 in human MFSD2A), and is localized to the plasma
membrane (data not shown), as previously demonstrated [18,30].
In mouse liver and BAT, MFSD2A is expressed as two major
species – a predicted non-glycosylated 59 kDa form and
a glycosylated ,70 kDa form (Fig. 1A). The brain expresses only
one ,65 kDa species of MFSD2A (Fig. 1A).
Mfsd2a mRNA has previously been shown to be upregulated in
liver and BAT by fasting and in BAT by cold exposure [17].
Expression of MFSD2A was undetectable in the liver of ad libitum
fed wildtype mice, but significant induction was observed in livers
from fasted wildtype mice (Fig. 1A). Contrary to the robust mRNA
induction of Mfsd2a in BAT [17], the induction of MFSD2A
protein by fasting was modest (Fig. 1A). Refeeding of fasted mice
resulted in a return of MFSD2A protein to baseline in both liver
and BAT. Expression of MFSD2A in whole brain was constitutive
and did not appear to be fasting-regulated (Fig. 1A). Expression is
absent in white adipose tissue (WAT) (Fig. 1A).
With a focus on MFSD2A regulation in liver, we sought to
determine the transcriptional pathways that mediate its nutritional
regulation. Since many fasting-induced genes are regulated by the
nuclear hormone receptor PPARa [31], we used PPARa KOmice
to genetically test that PPARa was necessary for the fasting-
induced expression of MFSD2A. Fasted PPARa KOmice failed to
induce MFSD2A compared to wildtype controls (Fig. 1B). Given
that glucagon plays a dominant role in regulating liver metabolism
during a fast [32,33], and that glucagon signaling has been shown
to synergize with PPARa for induction of genes in the liver
[34,35], we explored the possibility that glucagon signaling was
additionally required for fasting induction of MFSD2A. Indeed,
fasted glucagon receptor KO mice failed to induce MFSD2A in
the liver (Fig. 1C). Together, these findings indicate a dependence
on both PPARa and glucagon signaling for upregulation of
MFSD2A in response to fasting.
Since we observed loss of MFSD2A protein expression upon
refeeding (Fig. 1A), we sought to determine the kinetics of
MFSD2A down-regulation following refeeding. Wildtype mice
were fasted for 24 h from dark cycle to dark cycle, and followed
over a time course of 9 h of ad libitum refeeding at the onset of the
second dark cycle (Fig. 1D). Expression of MFSD2A was
expectedly high at the end of 24 h fast/start of refeeding (t = 0)
and during the subsequent first hour of access to food (t = 1 h). By
3 h of refeeding, MFSD2A was undetectable, indicating rapid
down-regulation. Interestingly, by t = 9 h of refeeding and
approaching the beginning of the next light cycle, protein
expression had begun to increase.
Our findings indicate that MFSD2A protein expression is tightly
regulated by fasting and refeeding, suggesting that in addition to
transcriptional control [17], MFSD2A protein turnover might be
important to controlling hepatic MFSD2A levels. To test this idea,
we determined the half-life of MFSD2A protein expressed from
a strong promoter in HEK293 cells, as well as turnover of
endogenous MFSD2A from primary hepatocytes. HEK293 cells
expressing mouse MFSD2A and mouse primary hepatocytes were
treated with cycloheximide to block ongoing translation, and
MFSD2A protein levels were quantified over a time course.
Degradation of MFSD2A occurred with a half-life of approxi-
mately 60 min in HEK293 cells and primary hepatocytes (Fig. 2A).
Biotin labeling of the cell surface of HEK293 cells indicated that
MFSD2A turnover occurred from the plasma membrane with
a similar rate as determined in whole cell lysates (Fig. 2B). In
addition, inhibition of lysosomal function using chloroquine, but
not the proteosome inhibitor MG-132, inhibited MFSD2A
turnover in the presence of cycloheximide (Fig. 2C–D), indicating
that MFSD2A turnover from the plasma membrane results in its
degradation in lysosomes.
Mfsd2a KO Mice are Leaner, with Less Serum and Tissue
Triglyceride
Based on our finding that fasting induction of MFSD2A in the
liver is dependent on PPARa and glucagon signaling, we
hypothesized that MFSD2A plays a physiological role in lipid
metabolism in response to a fast. To test this hypothesis, we
Figure 6. Mfsd2a KO mice have decreased adiposity but
normal lipolysis. A, WT and B, KO WAT depots stained with H&E. C,
NEFA measurements after a 4 h fast (baseline) and 15 min after an
injection of adrenergic agonist CL316243 (stimulated). D, Lipolysis was
assayed by measuring NEFA (left panel) and glycerol (right panel)
production over two hours, with and without isoproterenol (ISO)
stimulation, from WAT explants isolated from fasted WT and KO mice.
Data are displayed as mean 6 SEM. ** p,0.01, *** p,0.001.
doi:10.1371/journal.pone.0050629.g006
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generated a conventional gene-targeted mouse model of MFSD2A
deficiency (Fig. 3A). Offspring derived from Mfsd2a heterozygous
intercrosses resulted in the recovery of all Mfsd2a genotypes
(Fig. 3B). MFSD2A protein levels in the livers and brains from
fasted mice displayed dependency on gene-dosage (Fig. 3C). While
fasting did not strongly induce MFSD2A in BAT (Fig. 1A), cold
exposure of wildtype mice made brown adipose MFSD2A, which
is absent in the KO littermates, easier to detect (Fig. 3D). We also
observed low-level expression of MFSD2A protein in kidney,
testes, spinal cord, and placenta. MFSD2A protein was not
detected in heart, lung, spleen, or WAT (Fig. 3E). MFSD2A was
expressed in multiple anatomical regions in the brain but was not
Figure 7. Mfsd2a KO mice have increased energy expenditure. A–D, Indirect calorimetric analysis of male WT (white bars) and KO (dark bars)
mice (n = 4, 12–14 weeks of age) under ad libitum fed (left column) and fasted (right column) conditions for A, VO2, B, VCO2, C, energy expenditure
(EE), and D, respiratory quotient (RER). 1 p,0.05, # p,0.001.
doi:10.1371/journal.pone.0050629.g007
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induced by fasting (Fig. 3F). Based on the nutritional regulation of
MFSD2A expression, we primarily focused on characterizing
phenotypes within liver and BAT.
Mfsd2a heterozygous mice developed normally and were fertile.
Divergence from Mendelian inheritance was observed at post-
natal day 10 from heterozygous intercrosses indicating increased
mortality of both male and female Mfsd2a KO mice (Fig. 4A).
Normal Mendelian ratios were found at embryonic day 18.5,
indicating that the loss of Mfsd2a KO genotype occurs early in
postnatal life. By two weeks of age, male and female KO mice
weighed significantly less than wildtype and heterozygous
littermates (Fig. 4B, female data not shown). As seen in the
growth curves, this weight difference is maintained and accentu-
ated as the mice age. Additionally, the KO mice are shorter in
length than wildtype littermates (Fig. 4C). In male KO mice, body
adiposity as determined by EchoMRI was significantly decreased
in absolute fat mass (Fig. 4D). Despite the differences in body size,
measurement of food intake indicated that KO mice consumed
similar amounts of food as their wildtype littermates (Fig. 4E).
Glucose homeostasis, measured by glucose tolerance tests (Fig. 4F)
and fed and fasting serum glucose (Fig. 4G), showed no difference
between chow-fed wildtype and KO mice. KO mice showed
a significant decrease in total fasting (20 hr fast) plasma
triglycerides (TG) with no significant differences in fasting glucose,
total cholesterol, non-esterified FA, and ketones (Fig. 4G). Free T3
and T4 thyroid hormone levels were normal in KO mice (Fig. 4G).
Mfsd2a KO Mice have Normal Liver Physiology but
Increased Energy Expenditure
Because fasting induces MFSD2A, and knockout mice exhibit
reduced adiposity and serum TG, we wanted to determine
whether an overnight fast of Mfsd2a KO mice would result in
altered TG deposition in liver. It is well established that overnight
fasting of mice results in significant accumulation of liver
triglyceride [36–38]. Oil red-O stained liver sections from fasted
wildtype and Mfsd2a KO mice indicated a significantly reduced
accumulation of neutral lipid in livers of Mfsd2a KO mice (Fig. 5A
vs. 5B). We confirmed this observation by enzymatic quantifica-
tion of liver TG (Fig. 5C). However, the fold-increase in liver TG
from fed to fasted state in both wildtype littermates and Mfsd2a
KO mice was not significantly different (WT 2.4-fold vs. KO 2.7-
fold, p= 0.33).
Among the explanations for decreased TG load within the liver
are an increase in b-oxidation, decreased FA uptake, decreased
TG biosynthesis, and increased VLDL production, or inadequate
substrate availability due to changes in lipolysis or overall
decreased fat mass. Liver b-oxidation in fasted Mfsd2a KO mice
was not significantly different than wildtype littermates (Fig. 5D).
No significant differences were measured for the uptake of 14C-
oleate in vivo into liver (Fig. 5E). This is consistent with the finding
that expression of MFSD2A in HEK293 cells did not affect fatty
acid or glycerol incorporation into TG and phospholipids (Fig. 5F).
Interestingly, WAT from KO mice showed decreased oleate
uptake in vivo relative to wildtype, which is likely a secondary effect
of Mfsd2a deficiency because Mfsd2a is not expressed in WAT
(Fig. 1A). VLDL production was significantly decreased at 2 h and
4 h of measuring VLDL production in KO relative to wildtype
mice (Fig. 5G–H). Note that KO and wildtype had similar plasma
TG after a 4 hr fast (Fig. 5G), but KO levels were significantly
decreased after a 20 hr fast (Fig. 4G). Additionally, PPARa targets
in liver involved in FAO, as well as genes important for fatty acid
synthesis and lipid signaling, were largely unchanged, with the
exception of increased FASN expression (Fig. 5I). Lastly, in line
with normal glycemia in KO mice, decreased hepatic fat in KO
mice did not alter hepatic glucose production, as determined by
pyruvate tolerance test (Fig. 5J).
Histology of WAT revealed smaller adipocytes in KO tissue
(Fig. 6A vs. 6B), consistent with reduced fat mass (Fig. 4D). We
next tested if decreased fat mass in Mfsd2a KO mice was due to
changes in adipocyte lipolysis. In vivo stimulation of lipolysis
indicated no significant difference in KO mice (Fig. 6C),
suggesting that increased sympathetic activity in KO mice is not
the cause for decreased adipocyte size and mass. Ex vivo lipolysis
assays using adipose tissue explants confirmed these in vivo findings
that KO WAT exhibits comparable lipolysis to wildtype depots
Figure 8. Mfsd2a KO mice have increased, ataxic movement. A,
X-Y movement and B, Z-axis movement under ad libitum fed (left
column) and fasted (right column) conditions for WT and KO cohorts
from Fig. 7. C, Rotarod analysis to quantitatively assess motor
coordination in WT and KO littermates (n.7). Data are displayed as
mean 6 SEM. * p,0.05, ** p,0.01, *** p,0.001.
doi:10.1371/journal.pone.0050629.g008
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(Fig. 6D). Taken together, the data indicate that decreased liver
TG in Mfsd2a KO mice in fed and fasted state is likely due to
decreased whole body adiposity and not due to enhanced FAO,
decreased FA uptake capacity, or increased VLDL secretion.
We examined whether increased whole-body energy expendi-
ture could explain the phenotype of leaner body composition, and
thus decreased liver TG. To do so, we measured energy
expenditure using indirect calorimetry. KO mice had significantly
increased VO2, VCO2, and energy expenditure, particularly
during the dark cycle during ad libitum feeding, and light cycle in
the fasted state (Fig. 7A–C). RER was increased in fed KO mice,
though wildtype and KO mice reacted similarly to fasting,
indicating that the KO mice retained overall metabolic flexibility
for substrate utilization (Fig. 7D).
No statistically significant difference in movement was seen
among ad libitum fed mice (Fig. 8A). Interestingly, ambulation
(activity in the X-Y plane) was significantly higher in the fasted
KO compared to wildtype littermates, particularly during the
dark, food-seeking cycle (Fig. 8A). Conversely, rearing (Z-axis
movement) was significantly depressed in fasted KOmice (Fig. 8B).
To confirm this observation, we conducted rotarod testing to
determine whether decreased rearing indicated a defect in motor
coordination. Performance of KO mice on a rotarod indicated
that KO mice had a pronounced ataxia (Fig. 8C).
Since Mfsd2a KO mice exhibited increased energy expenditure,
we hypothesized that KO mice would be protected from high fat
diet-induced weight gain. To test this hypothesis, we challenged
Mfsd2a KO and wildtype littermates with a 60% kcal fat diet
(HFD) for 10 weeks, starting at six weeks of age. Throughout the
experimental time-course, male Mfsd2a KO mice were protected
from diet-induced obesity, weighing similar to KO mice fed chow
diet and significantly less than wildtype HFD animals (Fig. 9A).
Measurements of body composition of the cohorts at 10 days of
HFD (Fig. 9B) and 10 weeks of HFD (Fig. 9C) confirm the lean
nature of the KO animals. Despite the protection from obesity, by
10 weeks of HFD feeding, wildtype and KO mice had similar
levels of hepatosteatosis (Fig. 9D vs. 9E) and were similarly
glucose-intolerant (Fig. 9F).
Mfsd2a KO Mice have Increased FAO in BAT
In light of data suggesting a role for MFSD2A in BAT activation
in the setting of cold-induced thermogenesis and adrenergic
stimulation [17], we used the Mfsd2a KO animals to assess BAT
function. We observed a similar histologic phenotype to the liver in
KO BAT, where KO samples appeared densely eosinophilic, with
fewer multilocular lipid droplets compared to wildtype (Fig. 10A
vs. 10B). Total TG content was significantly decreased (Fig. 10C).
Importantly, the oxidative capacity of the subscapular BAT
depots, measured by ex vivo oxidation assays, was significantly
Figure 9. Mfsd2a KO mice develop glucose intolerance but are resistant to diet-induced obesity. A, Growth curves for WT and KO male
mice fed chow or high-fat diet (HFD) starting at 6 weeks of age (n = 4–8 per genotype). B and C, Average body weight (left), absolute adiposity
(center), and relative adiposity (right) for WT (open bar) and KO (closed bar) cohorts fed B, 10 days and C, 10 weeks of HFD. D, WT and E, KO livers
stained with ORO for neutral lipid following 10 weeks of HFD. F, GTT after overnight fast of WT and KO males fed HFD for 10 weeks (n = 3–4 mice per
genotype, data representative of two independent experiments). Data are displayed as mean 6 SEM. * p,0.05, ** p,0.01, *** p,0.001, N.S. = not
significant.
doi:10.1371/journal.pone.0050629.g009
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higher in KO BAT relative to wildtype BAT (Fig. 10D). As other
oxidative genes showed no changes in message level (Fig. 10E),
and there was no increase in mitochondrial number (Fig. 10F–G),
this may indicate a role for MFSD2A in regulation of BAT
oxidation. Lastly, Mfsd2a KO mice, regardless of the reduced
BAT TG content, were able to defend their body temperature
during cold challenge as well as their fasted wildtype littermates
(Fig. 10H).
Discussion
In this study, we have determined that MFSD2A plays roles in
lipid metabolism, body growth, and motor coordination.
MFSD2A is doubly glycosylated and localized to the cell surface,
consistent with findings regarding other members of the Major
Facilitator Superfamily [17,18,30]. Previous data have indicated
circadian control in Mfsd2a mRNA expression [17,39], and
suggests that downregulation of expression might be under the
control of RORa1 and RORc1 [17]. Here we extend these
findings and have shown that MFSD2A protein expression during
fasting is dependent on PPARa and glucagon signaling (Fig. 1B,
C), and exhibits rapid turnover in the liver following refeeding
(Fig. 1D). MFSD2A protein expression is tightly regulated with
a half-life of less than 60 min in cell culture (Fig. 2A). Of note,
expression in the brain is constitutive, ubiquitous, and not fasting-
induced as in liver or BAT (Fig. 3F).
Mfsd2a KO mice are leaner and smaller than wildtype
littermates and consistently have less TG in liver (Fig. 5C), BAT
(Fig. 10C) and serum (Fig. 4G). The overall reduced adiposity and
body size could represent a developmental defect or chronic
adaptation to loss of MFSD2A. This idea is supported by the
observations that the fold increase in TG accumulation in livers of
Mfsd2a KO mice following a fast was similar to wildtype
littermates, KO mice have unchanged liver fatty acid oxidation,
and reduced VLDL production relative to wildtype (Fig. 5).
Alternatively, MFSD2A KO mice have a significant increase in
whole-body energy expenditure (Fig. 7C), particularly during the
light cycle of fasted mice when MFSD2A would be induced. While
liver fatty acid metabolism appeared normal and unable to
account for this expenditure, BAT activity was significantly
increased in Mfsd2a KO mice (Fig. 10D). BAT activity in rodents
has been correlated with regulation of body weight in response to
increased caloric intake [40–42]. Moreover, increased brown
adipose FAO could also explain decreased plasma triglycerides
and potentially liver triglycerides [43]. The observation that
MFSD2A induction by fasting requires PPARa and glucagon
signaling would have intuitively suggested that MFSD2A, like
many other PPARa and glucagon targets, plays a role in activating
FAO. However, our findings here do not support this conclusion,
since liver FAO was unchanged and BAT FAO was increased in
KO mice. In short, the phenotype of the MFSD2A deficient
mouse resembles neither the PPARa nor Gcgr KO models
[10,21,22,35]. Our data more likely support the conclusion that
MFSD2a does not regulate PPARa or glucagon signaling, but
rather the increased BAT FAO is an adaptive response to loss of
neuronal MFSD2A. Indeed, the brain is the primary tissue of
expression of Mfsd2a and efferent signals from the brain are
known to regulate BAT activity [11,44–47].
In addition to increased BAT oxidation, Mfsd2a KO mice
exhibited significantly increased voluntary movement, but with
Figure 10. Mfsd2a KO mice have increased BAT b-oxidation. H&E staining of BAT depots from fasted A, WT and B, KO mice. C, Quantification
of TG from WT and KO BAT (n.7 per genotype). D, Assay of b-oxidation in BAT explants from fasted WT and KO littermates (n = 4). E, Real-time PCR
analysis of PPARa and PPARa targets in BAT from fasted WT and KO mice. F, Quantification of mitochondrial genome numbers from the ddCT of real-
time PCR signal for COX-II (mitochondrial) to UCP1 (nuclear) DNA from BAT (n.4). G,Western blots probed for BAT mitochondrial membrane proteins
Tom20, COX-IV and UCP1 from fasted WT and KO mice (n = 3). H, Body temperature measurements to assess cold-induced (non-shivering)
thermogenesis in cohorts of fasted WT, HET, and KO mice (n = 3–4 per genotype) exposed to 4uC. Data are displayed as mean 6 SEM. * p,0.05,
** p,0.01.
doi:10.1371/journal.pone.0050629.g010
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surprisingly decreased motor coordination (Fig. 8A and 8C) [48–
50]. Both the motor deficits and BAT activity strongly suggest
a central effect of MFSD2A action. In addition to the neurologic
changes observed, Hogenesch and co-workers [39] recently
determined that mouse Mfsd2a is primarily under central nervous
system (CNS) clock control for circadian expression, and not liver
clock control. Hogenesch and co-workers raise the intriguing idea
that Mfsd2a serves to deliver nutritional signals to the liver clock.
Whether the CNS- or liver-expressed Mfsd2a plays any role in
circadian control of metabolism remains to be determined.
Regardless, the combination of increased voluntary movement
and increased BAT activity likely accounts for the increased
energy expenditure, and thus the lean nature of the MFSD2A KO
mice, including protection from diet-induced weight gain (Fig. 9A).
The small size and post-natal lethality of Mfsd2a KO mice are
notable since MFSD2A is expressed in placenta, and human
MFSD2A has been shown to be the receptor for the syncytio-
trophoblast fusion factor syncytin-2 [18]. However, Heidmann
and coworkers have demonstrated that mouse MFSD2A is not
a receptor for mouse syncytin-A or -B, the murine syncytin
homologs. Moreover, syncytin-A deficiency results in early
embryonic lethality, while mice lacking syncytin-B experience late
onset growth retardation but without any post-natal lethality as
observed in Mfsd2a KO mice [51,52]. It remains to be determined
whether MFSD2A plays a role in placental development, and
whether possible defects in placental function are responsible for
the small post-natal size and mortality of Mfsd2a KO mice, as well
as the metabolic changes reported here. The Mfsd2a KO model
may yet provide interesting observations about the role of
MFSD2A in placentation.
Clearly, identification of the physiological ligand(s) transported
by MFSD2A will provide great insight into the physiological
function of MFSD2A. Mfsd2a has limited homology to the
bacterial disaccharide melibiose transporter [17], and may have
the capacity to transport the bacterial-derived glycosylation
inhibitor tunicamycin [30]. While we did not find MFSD2A
capable of transporting glucose, fatty acids, pyruvate, ketones, or
select amino acids (data not shown), and Sabatini and co-workers
reported an absence of transport of melibiose [30], it is possible
based on the suggested transport of tunicamycin, itself an acylated
disaccharide, that the endogenous substrate may be a metabolically
active glycolipid.
While MFSD2A expression is tightly regulated in the liver and
BAT, it is ubiquitously expressed in the brain (Fig. 3F). Based on
prominent hyperactivity (Fig. 8A) and ataxia (Fig. 8C), as well as
the small body size (Fig. 4B–C) and early post-natal death (Fig. 4A)
of Mfsd2a KO mice, it is likely that MFSD2A plays a profound
role in brain metabolism. Only through future identification of its
ligand(s) will these questions about the central role of MFSD2A be
answered.
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